Numoda Capital Innovations

Numoda Capita Innovations is a corporate venture capital firm in Pennsylvania that focuses on the life science and novel technologies sectors. Founded 2009 in Philadelphia, Pennsylvania, United States, it invests in early stage ventures and late stage ventures. Its portfolio companies include Evofem Biosciences and MabVax TherapeuticsMabVax Therapeutics. As of March 2020, Numoda Capital Innovations has made two investments. Their most recent investment was on December 19, 2012, when Evofem Biosciences raised $20.6M. Numoda Capital Innovations has had two exits, the most notable of which include Evofem Biosciences and MabVax Therapeutics.

Numoda Capita Innovations is a corporate venture capital firm in Pennsylvania that focuses on the life science and novel technologies sectors. Founded 2009 in PhiladelphiaPhiladelphia, Pennsylvania, United States, it invests in early stage ventures and late stage ventures. Its portfolio companies include Evofem Biosciences and MabVax Therapeutics. As of March 2020, Numoda Capital Innovations has made two investments. Their most recent investment was on December 19, 2012, when Evofem Biosciences raised $20.6M. Numoda Capital Innovations has had two exits, the most notable of which include Evofem Biosciences and MabVax Therapeutics.

Numoda Capita Innovations is a corporate venture capital firm in PennsylvaniaPennsylvania that focuses on the life science and novel technologies sectors. Founded 2009 in Philadelphia, Pennsylvania, United States, it invests in early stage ventures and late stage ventures. Its portfolio companies include Evofem Biosciences and MabVax Therapeutics. As of March 2020, Numoda Capital Innovations has made two investments. Their most recent investment was on December 19, 2012, when Evofem Biosciences raised $20.6M. Numoda Capital Innovations has had two exits, the most notable of which include Evofem Biosciences and MabVax Therapeutics.

Numoda Capita Innovations is a corporate venture capital firm in Pennsylvania that focuses on the life science and novel technologies sectors. Founded 2009 in Philadelphia, Pennsylvania, United States, it invests in early stage ventures and late stage ventures. Its portfolio companies include Evofem BiosciencesEvofem Biosciences and MabVax Therapeutics. As of March 2020, Numoda Capital Innovations has made two investments. Their most recent investment was on December 19, 2012, when Evofem Biosciences raised $20.6M. Numoda Capital Innovations has had two exits, the most notable of which include Evofem Biosciences and MabVax Therapeutics.

Numoda Capita Innovations is a corporate venture capital firmventure capital firm in Pennsylvania that focuses on the life science and novel technologies sectors. Founded 2009 in Philadelphia, Pennsylvania, United States, it invests in early stage ventures and late stage ventures. Its portfolio companies include Evofem Biosciences and MabVax Therapeutics. As of March 2020, Numoda Capital Innovations has made two investments. Their most recent investment was on December 19, 2012, when Evofem Biosciences raised $20.6M. Numoda Capital Innovations has had two exits, the most notable of which include Evofem Biosciences and MabVax Therapeutics.

Numoda Capita Innovations is a corporate venture capital firm in Pennsylvania that focuses on the life science and novel technologies sectors. Founded 2009 in Philadelphia, Pennsylvania, United StatesUnited States, it invests in early stage ventures and late stage ventures. Its portfolio companies include Evofem Biosciences and MabVax Therapeutics. As of March 2020, Numoda Capital Innovations has made two investments. Their most recent investment was on December 19, 2012, when Evofem Biosciences raised $20.6M. Numoda Capital Innovations has had two exits, the most notable of which include Evofem Biosciences and MabVax Therapeutics.

Numoda Capita Innovations is a corporate venture capital firm in Pennsylvania that focuses on the life science and novel technologies sectors. Founded 2009 in Philadelphia, Pennsylvania, United States, it invests in early stage ventures and late stage ventures. Its portfolio companies include Evofem Biosciences and MabVax Therapeutics. As of March 2020, Numoda Capital Innovations has made two investments. Their most recent investment was on December 19, 2012, when Evofem Biosciences raised $20.6M. Numoda Capital Innovations has had two exits, the most notable of which include Evofem Biosciences and MabVax Therapeutics.